A little Prozac makes guppies most peculiar.
Pierson Hill

A little Prozac makes guppies most peculiar.

Exposed guppies freeze up, hide out, and move around less after a simulated attack. Such behaviors do not bode well for fish populations.

A little bit of an anti-depressant makes wild guppies less active, camp out more under plants and freeze up for longer after something scares them, according to a new study.


The latest research out of Australia adds to mounting evidence that one the world’s most widely prescribed drugs—fluoxetine, most commonly known by the trade name Prozac—is getting flushed into waterways and making fish act different. And different isn’t good: The drug appears to be changing habits designed to keep fish alive and reproductive.

Fluoxetine, used to treat depression and anxiety, is the third most prescribed drug in the U.S., with about 28 million prescriptions annually. The drug is frequently found in waterways by way of people excreting the drug or flushing pills.

Credit: Jake Martin

Researchers collected wild adult guppies from Queensland, Australia, and put 60 fish in tanks with a low dose of fluoxetine, 60 in with a high dose and 60 in drug-free water. After 28 days they started testing their behavior, specifically simulating a bird strike and seeing how they responded. They used a fake heron, a bird that preys on guppies, and had it strike into the center of the tank and then immediately retract.

"There is no doubt those are environmentally relevant treatment levels, and there’s no doubt there are changes in behavior."-Bryan Brooks, Baylor UniversityFish exposed to fluoxetine remained stationary (called “freezing”) for longer and spent more time under plant cover. Both freezing and heading to plant cover are anti-predator behaviors for fish and are crucial to their survival.

“There is no doubt those are environmentally relevant treatment levels, and there’s no doubt there are changes in behavior,” said Bryan Brooks, a professor of environmental science at Baylor University who was not involved in the study.

The findings, published in the journal Aquatic Toxicology, were sex-specific, with dosed females spending more time under plant cover and dosed males becoming less exploratory. These may seem small changes but they’re important for tiny fish often preyed upon. “Time and energy used in remaining stationary is diverted from other fitness-related activities, such as foraging and finding mates,” said lead author Minna Saaristo, a research associate at Monash University in Australia, via email. 

Saaristo said that male guppies benefit from being “bold and exploring new territories” to find mates, so any changes to their behavior could harm the overall fish population.

Anti-depressants, such as fluoxetine, work by increasing serotonin function in the brain. This system of the brain is similar across vertebrates, Saaristo said. Drugs that affect human brains can and will affect fish brains.

“These drugs are intended to alter behavior,” Brooks said.

More than a decade ago Brooks and colleagues were the first to find anti-depressants in fish. They reported fluoxetine and other drugs in every liver, brain and filet tissues they tested from fish in a north Texas stream. 

Since then multiple studies have shown fluoxetine is not only accumulating in fish but altering behavior.

In a landmark 2013 study, University of Wisconsin-Milwaukee researchers found that fluoxetine-exposed male minnows were anxious, anti-social and aggressive—in some cases killing females.  The lab work suggested that the drugs altered how genes in the fish brains were expressed, or turned on and off. The minnows were exposed when they were a couple of months old and still developing.

Last March University of New England researchers reported that male Siamese fighting fish were less aggressive and bold after fluoxetine exposure. 

Brooks said two of the current study’s strengths were using guppies—which are not routinely studied—and dosing at levels that are commonly found in waterways.

Brooks said he is encouraged to see such studies specifically looking at fish behavior. Pharmaceuticals are still tricky compounds that can “fall through the regulatory cracks,” he said. Traditionally water contaminants—think pesticides and metals—have been tested for toxicity but not the subtle behavioral changes Saaristo and others are reporting.

It’s important to look for behavioral changes to aquatic creatures, Brooks said, because our waters increasingly have pharmaceuticals such as fluoxetine, and certain endocrine disrupting compounds, that may not prove acutely toxic but alter behavior and development.

Saaristo said the next step for her research group is to tease out if there are indeed fish population-level impacts from the fluoxetine exposure.

About the author(s):

Brian Bienkowski
Brian Bienkowski

Brian Bienkowski is the managing editor at The New Lede and a former senior news editor at Environmental Health News.

You Might Also Like

Recent

Top environmental health news from around the world.
Agents of Change launches the Fellows in Residence program
Climate

Agents of Change launches the Fellows in Residence program

Meet the senior fellows that will hone their communication and public engagement skills.

EHN reporters win four Golden Quill Awards
Climate

EHN reporters win four Golden Quill Awards

Cami Ferrell and Kristina Marusic received recognition for their investigative reporting on hydrogen energy and chemical recycling.

Millions in the U.S. may rely on PFAS-contaminated drinking water
Originals

Millions in the U.S. may rely on PFAS-contaminated drinking water

As the Trump administration delays limits on forever chemicals in drinking water, a new model predicts the locations of contaminated groundwater, exposing potential widespread health risks and monitoring gaps.

Op-ed: To curb chronic disease in Americans, the FDA needs to assert regulatory control over toxic chemicals in our food
Originals

Op-ed: To curb chronic disease in Americans, the FDA needs to assert regulatory control over toxic chemicals in our food

FDA reform — not just narrow ingredient bans — is needed to make America healthier.

Opinion: Investors should address the risk from undisclosed hazardous chemicals in investment portfolios
Toxics

Opinion: Investors should address the risk from undisclosed hazardous chemicals in investment portfolios

Consumer product and manufacturing investments are vulnerable to hidden risk from unknown or undisclosed hazardous chemicals. New tools can help.

Another PFAS-containing pesticide headed for US registration
Originals

Another PFAS-containing pesticide headed for US registration

“This is a PFAS and if it’s going to be applied that means more PFAS in the environment and communities need to be aware of that, especially with what we’ve seen with water contamination."

Environmental Health News

Your support of EHN, a newsroom powered by Environmental Health Sciences, drives science into public discussions. When you support our work, you support impactful journalism. It all improves the health of our communities. Thank you!

donate
Multiple Houston-area oil and gas facilities that have violated pollution laws are seeking permit renewals
Originals

Multiple Houston-area oil and gas facilities that have violated pollution laws are seeking permit renewals

One facility has emitted cancer-causing chemicals into waterways at levels up to 520% higher than legal limits.

Book excerpt: Detoxify
Originals

Book excerpt: Detoxify

"Many researchers believe that the United States’s skyrocketing rates of autoimmune disease in the last thirty years is due to the country’s concurrent skyrocketing rates of chemical exposure."

Pennsylvania health advocates say Trump’s first 100 days in office have caused “100 harms” to local communities
Originals

Pennsylvania health advocates say Trump’s first 100 days in office have caused “100 harms” to local communities

“They're terrorizing these scientists because they want to keep them silent.”